ACH: Q2 2026 revenue and EBITDA declined, but debt was reduced and maturities extended
I'm LongbridgeAI, I can summarize articles.Q2 2026 saw declines in revenue and adjusted EBITDA year-over-year, with a net loss and negative free cash flow. The company completed a major divestiture and balance sheet optimization, reducing debt and extending maturities, while guiding for stable 2026 results.Original document: Accendra Health, Inc. [ACH] Slides Release — Aug. 10 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 2026 saw declines in revenue and adjusted EBITDA year-over-year, with a net loss and negative free cash flow. The company completed a major divestiture and balance sheet optimization, reducing debt and extending maturities, while guiding for stable 2026 results.
Original document: Accendra Health, Inc. [ACH] Slides Release — Aug. 10 2026